MEAGAN DAVIS: Open Payments
NPI 1962054346 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 27 payments from 11 companies in 2025. Trend: 2023 $167 · 2024 $547 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $295 |
| Hologic Sales and Service, LLC | 3 | $242 |
| Corium, LLC | 7 | $131 |
| Supernus Pharmaceuticals, Inc. | 1 | $114 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $111 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| ALK-Abello, Inc | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: APTIMA, NEFFY, REPATHA, Azstarys, Qelbree, VPRIV, ROTATEQ, KOSELUGO.
Industry payments across TX — which companies pay providers there.
